Bevin Fletcher
Digital Editor

Bevin Fletcher is the Digital Editor of Bioscience Technology, where she oversees editorial content for the website and the Bioscience Technology Weekly e-newsletter and contributes to Lab Outlook. Bevin graduated with a Bachelor’s degree in journalism and was previously a reporter at The Deal.  She writes on a variety of topics in the life sciences world such as genomics, disease research, neurology and biotechnology, and interviews researchers and industry experts on their work.  If you are interested in getting the word out on a particular trend or topic, please reach out to her at bevin.fletcher@advantagebusinessmedia.com.

Creativity might not be a “right-brain” thing after all – but rather the ability of both hemispheres to communicate. A new study from Duke University reveals...
2.24.2017
10:46am
A panel of industry executives came together Feb. 13 at the BIO CEO and Investor Conference in New York City, to discuss challenges in treating pain, and new...
2.23.2017
10:15am
French biopharmaceutical company PharNext SA is taking a different approach to drug development, by identifying new indications for novel combinations of off-...
2.22.2017
10:17am
An expert panel convened in New York City on Feb. 14, at the BIO CEO and Investor Conference to discuss public health policy under the new Administration and...
2.17.2017
11:25am
Exhibitors flocked to Washington D.C. last week for the Society of Laboratory Automation and Screening's 2017 conference to show off the newest...
2.10.2017
10:56am
Advertisement
On Wednesday at the Society for Laboratory Automation and Screening 2017 conference in Washington D.C., judges announced three winners of the New Product Award.
2.9.2017
12:08pm
Yale scientists identified a novel DNA repair defect in brain tumor cells that is very sensitive to a drug already approved by the Food and Drug Administration...
2.3.2017
10:32am
Many drugs targeting cancer block a single receptor or signaling pathway, but researchers from the University of California San Diego have reported on a new...
2.2.2017
10:09am
Privately-held biotech company, Clinical Genomics, has developed and launched a two-gene blood test for colorectal cancer recurrence monitoring that is capable...
2.1.2017
10:45am
Researchers from the Scripps Research Institute harnessed the power of induced pluripotent stem cells (iPSCs) to observe early brain changes that occur in...
2.1.2017
10:42am
Brain tissue is “programmed” for a person’s life during early developmental stages in the womb and during infancy, and getting enough Vitamin A at this time...
1.30.2017
9:58am
Researchers from the University of Missouri have created new software that can analyze any series of images, such as magnetic resonance imaging (MRI),...
1.30.2017
9:56am
The National Institutes of Health recently recognized two medical researchers with Outstanding Investigator Awards, which are the largest individual support...
1.27.2017
10:18am
Advertisement
A new study in mice and monkeys has found that a drug compound, known as an antisense oligonucleotide, can lower levels of tau proteins and potentially treat...
1.26.2017
10:31am
Tony Hoang did not grow up with much. As a boy he began tinkering with broken electronics his parents would buy at thrift stores, developing a knack for fixing...
1.25.2017
10:46am
A new study identified molecular and genomic characteristics of cervical cancer that will help to classify subtypes of the disease, as well as guide potential...
1.25.2017
10:26am
A small, Phase 1 trial has demonstrated safety and efficacy of fecal microbial transplants for the treatment of autism.
1.24.2017
11:08am
Centrexion Therapeutics announced positive results from its Phase 2b trial of patients with knee osteoarthritis pain, treated with CNTX-4975.
1.19.2017
11:00am
Two research teams joined together to help settle on ongoing controversy in aging research – whether caloric restriction in rhesus monkeys helped the animals...
1.18.2017
10:20am
Immunotherapy is one of the biggest things in oncology at the moment and San Carlos-based Lion Biotechnologies Inc., is pushing ahead using tumor-infiltrating...
1.17.2017
10:40am
Recent research in fruit flies suggests eating a niacin-rich diet could benefit people with early-onset Parkinson’s disease by boosting levels of the compound...
1.13.2017
9:54am
Advertisement
San Diego-based Halozyme Therapeutics Inc., announced that the Phase 2 study of its lead investigational drug, PEGPH20, in patients with advanced pancreas...
1.13.2017
9:52am
Scientists have applied CRISPR-Cas9 gene editing techniques to take on the rare genetic immunodeficiency disorder, chronic granulomatous disease (CGD).
1.12.2017
10:07am
An international research team found detectable DNA methylation changes in obesity-prone mice that were only six-weeks old, that eventually promote the...
1.11.2017
10:01am
A new study adds to growing evidence that the Mediterranean diet has a positive impact on brain health.
1.10.2017
9:52am
A new study suggests that getting the recommended amount of activity in over one or two exercise sessions per week could be enough to offer substantial health...
1.10.2017
9:50am
The prevailing view is that brain development is associated with massive pruning of synapses, but a new study suggests that certain parts of the brain –...
1.9.2017
9:47am
Santa Cruz, Calif.- based startup Two Pore Guys (2PG) announced they are working with cancer researchers at the University of California, San Francisco, to...
1.9.2017
9:46am
Industry leaders came together in December to discuss one of the most important aspects of global healthcare – the patient.
1.6.2017
10:34am
A multicenter phase I clinical trial of the oral drug selumetinib has shown some early promising results in children diagnosed with neurofibromatosis type 1 (...
1.5.2017
10:13am
Heart disease is the number one killer of men and women in the U.S., and while some studies have suggested alcohol can have protective benefits for heart...
1.4.2017
9:50am
Some semi-arid plants use a specific type of photosynthesis known as crassulacean acid metabolism, or CAM, to conserve water and flourish in semi-arid climates.
1.3.2017
10:17am
Clinical-stage immuno-oncology company TapImmune Inc., is on the quest to beat down ovarian and breast cancer using vaccines that target T-cells on two fronts.
12.16.2016
10:20am
Human trials are in the works after new research in animal models suggests that an experimental drug first developed for type 2 diabetes could actually help...
12.15.2016
11:13am
Rock Health, a venture fund dedicated to digital health, has put out its second annual national survey on how consumers use digital health, here we look at...
12.14.2016
10:45am
Promising results of a clinical trial of a new drug, used in combination with chemotherapy, to treat newly diagnosed acute myeloid leukemia (AML) patients,...
12.13.2016
10:14am
Researchers from Oxford University’s Wellcome Trust Centre for Human Genetics (WTCHG) and genome analytics company Genomics plc, for the first time used a hand...
12.9.2016
9:54am
Researchers from the University of Liverpool have discovered that the gene for the protein p63 can help initiate cancer “cell suicide”, potentially killing the...
12.8.2016
10:40am
Genetic research company, Pairnomix LLC, presented a case study at the 70th Annual Meeting of the American Epilepsy Society in Houston, detailing an...
12.7.2016
11:16am